Project Grant R21AG088955
Award Date
9/15/24
Completion Date
8/31/26
Dollars Obligated
$234K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
The National Institute on Aging (NIA) awarded a $242,956 Project Grant under the Aging Research program (CFDA 93.866) to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The purpose of this 5-year K76 Career Development Award is to support Dr. Fullard's research to improve shared decision-making for older adults with cognitive impairment, using Parkinson's disease patients with mild cognitive impairment (MCI) as a model. The key objectives are to:...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) aims to advance health equity in the use of novel treatments for Alzheimer's disease and related dementias (ADRD). The $322,286 award to The Johns Hopkins University will fund a two-phase project. In the planning phase (R61), the researchers will conduct focus groups to understand medication decision-making processes of diverse individuals affected by ADRD. They will then design discrete choice experiments...
This $243,000 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support a 5-year study to identify factors associated with and barriers/facilitators to routine deprescribing of potentially inappropriate medications (PIMs) among older adults with Alzheimer's disease and related dementias (ADRD) receiving home health care. The study has two main aims: 1) Use a mixed methods approach to analyze existing data and engage stakeholders to further develop a...
This federal Project Grant award of $561,600 from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to characterize medication use and supports among people with dementia who live alone. The project aims to: Evaluate medication use and management supports for this population using national survey and Medicare claims data. Conduct qualitative interviews to understand medication-related experiences and needs from the perspectives of people with dementia who...
This federal Project Grant award of $1,846,173 from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to understand the impact of Medicare Advantage (MA) coverage on healthcare utilization and intergenerational transfers among patients with Alzheimer's disease and related dementias (ADRD). The 5-year project, running from August 2024 to April 2029, will examine differences in potentially preventable hospitalizations, burdensome transfers, and post-discharge...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $655,638 to the University of Denver to develop and test oligopyridylamide (OP)-based synthetic protein mimetics as potential therapeutics for Lewy body dementia (LBD). The key objectives are to (1) optimize the pharmaceutical properties of the OP compounds and (2) evaluate their ability to inhibit alpha-synuclein aggregation and rescue LBD phenotypes in mouse models. The research aims to...
This $334,788 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the impact of recent revisions to the Medicare home health payment system (Patient-Driven Groupings Model or PDGM) on access, care delivery, and outcomes for community-living Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The 2-year study, starting September 1, 2023, will leverage Medicare claims, home health assessment, and agency data to:...
This $308,000 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund the development and pilot testing of a shared decision-making (SDM) tool for surgeons to use with frail older adult patients considering major colorectal surgery. The tool aims to improve communication during the SDM process for this vulnerable patient population, which faces higher surgical complication rates and changes to quality of life. The project will utilize a Delphi process...
This $1,230,000 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports the development and delivery of closed-loop digital interventions through a remote clinical trials platform at the University of California, San Francisco (UCSF). The overarching goal is to leverage technology to facilitate memory and cognitive function in older adults, particularly those at risk of Alzheimer's disease and related dementias. The award will fund a Behavioral...
The National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), awarded a $499,796 Project Grant to Clear Session, Inc. to develop a personalized digital visualization tool to improve communication between clinicians, Latino Alzheimer's disease and related dementias (ADRD) patients, and their caregivers. The project, which runs from September 2024 to August 2025, aims to create a linguistically and culturally tailored solution that enhances healthcare...